An official ATS statement: hepatotoxicity of antituberculosis therapy

JJ Saukkonen, DL Cohn, RM Jasmer… - American journal of …, 2006‏ - atsjournals.org
Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-
standing concern in the treatment of tuberculosis (TB) infection. The liver has a central role …

MRGPRX2 and adverse drug reactions

BD McNeil - Frontiers in immunology, 2021‏ - frontiersin.org
Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought
to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug …

[PDF][PDF] Drug allergy: a 2022 practice parameter update

DA Khan, A Banerji, KG Blumenthal, EJ Phillips… - Journal of Allergy and …, 2022‏ - Elsevier
Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Antimicrobial safety: focus on fluoroquinolones

RC Owens Jr, PG Ambrose - Clinical infectious diseases, 2005‏ - academic.oup.com
Background/purpose. Infrequent toxicities associated with certain drugs and drug classes
have recently gained much attention from different health-care perspectives. To protect the …

[HTML][HTML] Quinolones in 2005: an update

F Van Bambeke, JM Michot, J Van Eldere… - Clinical Microbiology …, 2005‏ - Elsevier
Quinolones are one of the largest classes of antimicrobial agents used worldwide. This
review considers the quinolones that are available currently and used widely in Europe …

Hepatic safety of antibiotics used in primary care

RJ Andrade, PM Tulkens - Journal of Antimicrobial …, 2011‏ - academic.oup.com
Antibiotics used by general practitioners frequently appear in adverse-event reports of drug-
induced hepatotoxicity. Most cases are idiosyncratic (the adverse reaction cannot be …

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis

SE Dorman, JL Johnson, S Goldberg… - American journal of …, 2009‏ - atsjournals.org
Rationale: Moxifloxacin has potent activity against Mycobacterium tuberculosis in vitro and
in a mouse model of antituberculosis (TB) chemotherapy, but data regarding its activity in …

Safety considerations of fluoroquinolones in the elderly: an update

R Stahlmann, H Lode - Drugs & aging, 2010‏ - Springer
The fluoroquinolones ciprofloxacin, levofloxacin, moxifloxacin and gemifloxacin are widely
used for the treatment of various types of bacterial infections. Overall, these antibacterial …

Safety profile of the fluoroquinolones: focus on levofloxacin

HH Liu - Drug Safety, 2010‏ - Springer
The fluoroquinolone class of antibacterial agents are among the most frequently prescribed
drugs, with utility in a broad range of bacterial infections. Although very useful agents, the …

Allergenic and mas-related G protein-coupled receptor X2-activating properties of drugs: resolving the two

V Sabato, DG Ebo, MLM Van Der Poorten… - The Journal of Allergy …, 2023‏ - Elsevier
Since the seminal description implicating occupation of the Mas-related G protein-coupled
receptor X2 (MRGPRX2) in mast cell (MC) degranulation by drugs, many investigations …